avant
Generic: benzocaine
Labeler: dharma research, inc.Drug Facts
Product Profile
Brand Name
avant
Generic Name
benzocaine
Labeler
dharma research, inc.
Dosage Form
GEL
Routes
Active Ingredients
benzocaine 6.4 g/100g
Manufacturer
Identifiers & Regulatory
Product NDC
53045-140
Product ID
53045-140_33eb6c31-6bd2-4c7c-b7e3-01088def8fc7
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M022
Listing Expiration
2026-12-31
Marketing Start
2021-01-22
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
53045140
Hyphenated Format
53045-140
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
avant (source: ndc)
Generic Name
benzocaine (source: ndc)
Application Number
M022 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 6.4 g/100g
Packaging
- 32 g in 1 BOTTLE (53045-140-30)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["DENTAL"], "spl_id": "33eb6c31-6bd2-4c7c-b7e3-01088def8fc7", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "unii": ["U3RSY48JW5"], "spl_set_id": ["886d949b-8db1-499c-a277-174f8bc29f34"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Dharma Research, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "32 g in 1 BOTTLE (53045-140-30)", "package_ndc": "53045-140-30", "marketing_start_date": "20210122"}], "brand_name": "Avant", "product_id": "53045-140_33eb6c31-6bd2-4c7c-b7e3-01088def8fc7", "dosage_form": "GEL", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "53045-140", "generic_name": "Benzocaine", "labeler_name": "Dharma Research, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Avant", "active_ingredients": [{"name": "BENZOCAINE", "strength": "6.4 g/100g"}], "application_number": "M022", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210122", "listing_expiration_date": "20261231"}